APP and Alzheimer disease: The mRNA expression of APP, NTRK1, ESR1, CFTR, CSNK2A1, EGFR, ESR2, GSK3B, and PAK1 in the AS group showed a significant decrease compared with that of the AD group (P< 0.001, P< 0.0001).